Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
10.22
+0.15 (1.49%)
Oct 6, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Novel Therapeutics
3.95M
Log In
Log In
Log In
Novel Therapeutics Growth
-74.60%
Log In
Log In
Log In